Sanjay S. Subramanian
2022
In 2022, Sanjay S. Subramanian earned a total compensation of $1.2M as Senior Vice President and Chief Financial Officer at Inozyme Pharma.
Compensation breakdown
| Bonus | $105,000 |
|---|---|
| Non-Equity Incentive Plan | $189,200 |
| Option Awards | $522,141 |
| Salary | $430,000 |
| Other | $2,100 |
| Total | $1,248,441 |
Subramanian received $522.1K in option awards, accounting for 42% of the total pay in 2022.
Subramanian also received $105K in bonus, $189.2K in non-equity incentive plan, $430K in salary and $2.1K in other compensation.
Rankings
In 2022, Sanjay S. Subramanian's compensation ranked 2,604th out of 5,756 executives tracked by ExecPay. In other words, Subramanian earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,604 out of 5,756 | 55th |
Division Manufacturing | 1,446 out of 3,133 | 54th |
Major group Chemicals And Allied Products | 657 out of 1,419 | 54th |
Industry group Drugs | 610 out of 1,320 | 54th |
Industry Pharmaceutical Preparations | 438 out of 966 | 55th |
Source: SEC filing on April 27, 2023.
Subramanian's colleagues
We found two more compensation records of executives who worked with Sanjay S. Subramanian at Inozyme Pharma in 2022.